Explore our comprehensive coverage of eli lilly, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA has approved donanemab, a first-in-class monoclonal antibody for early-stage Alzheimer's disease, following the landmark TRAILBLAZER-ALZ 2 tri...
Read Full Story →
HealthThe FDA has officially approved the first highly effective daily oral pill for weight loss, matching...
World PoliticsEli Lilly is scaling up its Zepbound supply chain with new API facilities to eliminate shortages. Th...
MarketsEli Lilly (LLY) continues to be highlighted as one of the top stocks to buy for June 2026, driven by...
